Fusion Pharmaceuticals Inc. (FUSN)
NASDAQ: FUSN · IEX Real-Time Price · USD
21.42
+0.10 (0.47%)
Apr 23, 2024, 4:00 PM EDT - Market closed
Fusion Pharmaceuticals Market Cap
Fusion Pharmaceuticals has a market cap or net worth of $1.82 billion as of April 24, 2024. Its market cap has increased by 608.42% in one year.
Market Cap
1.82B
Enterprise Value
1.63B
1-Year Change
608.42%
Ranking
Category
Stock Price
$21.42
Market Cap Chart
Since June 26, 2020, Fusion Pharmaceuticals's market cap has increased from $708.30M to $1.82B, an increase of 156.64%. That is a compound annual growth rate of 27.95%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 22, 2024 | 1.81B | 0.28% |
Apr 19, 2024 | 1.80B | 0.05% |
Apr 18, 2024 | 1.80B | 0.04% |
Apr 17, 2024 | 1.80B | -0.09% |
Apr 16, 2024 | 1.80B | -0.09% |
Apr 15, 2024 | 1.80B | -0.14% |
Apr 12, 2024 | 1.80B | -0.23% |
Apr 11, 2024 | 1.81B | - |
Apr 10, 2024 | 1.81B | -0.09% |
Apr 9, 2024 | 1.81B | -0.09% |
Apr 8, 2024 | 1.81B | 0.38% |
Apr 5, 2024 | 1.81B | -0.52% |
Apr 4, 2024 | 1.82B | 0.43% |
Apr 3, 2024 | 1.81B | 0.23% |
Apr 2, 2024 | 1.80B | 0.19% |
Apr 1, 2024 | 1.80B | -0.33% |
Mar 28, 2024 | 1.81B | 0.09% |
Mar 27, 2024 | 1.80B | - |
Mar 26, 2024 | 1.80B | 0.57% |
Mar 25, 2024 | 1.79B | -0.28% |
Mar 22, 2024 | 1.80B | 0.19% |
Mar 21, 2024 | 1.80B | 0.52% |
Mar 20, 2024 | 1.79B | 16.47% |
Mar 19, 2024 | 1.53B | 99.07% |
Mar 18, 2024 | 770.40M | 6.51% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Avidity Biosciences | 1.93B |
Galapagos NV | 1.92B |
Owens & Minor | 1.86B |
BrightSpring Health Services | 1.82B |
Ginkgo Bioworks Holdings | 1.81B |
NewAmsterdam Pharma Company | 1.81B |
Astrana Health | 1.80B |
Syndax Pharmaceuticals | 1.78B |